AIC
FENC icon

AWM Investment Company’s Fennec Pharmaceuticals FENC Stock Holding History

AWM Investment Company’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Buy
1,160,296
+440,161
+61% +$3.59M 1.08% 28
2026
Q1 		$4.43M Buy
720,135
+8,266
+1% +$63.8K 0.49% 51
2025
Q4 		$5.48M Buy
+711,869
New +$5.84M 0.53% 54
2023
Q2 		– Sell
-47,600
Closed -$396K – 116
2023
Q1 		$396K Buy
+47,600
New +$441K 0.05% 109

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PCM
Potomac Capital Management New York $147M AUM

AWM Investment Company's FENC Position: Q2 2026 in Review

AWM Investment Company increased its Fennec Pharmaceuticals (FENC) stake by 61% in Q2 2026, buying an estimated $3.59M and bringing the position to 1,160,296 shares worth $12.5M. The position accounts for 1.08% of the portfolio, ranked #28.

AWM Investment Company first reported a position in FENC in Q1 2023 and has held it in 4 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • AWM Investment Company held 1,160,296 shares of Fennec Pharmaceuticals worth $12.5M as of Q2 2026.
  • AWM Investment Company bought 440,161 Fennec Pharmaceuticals shares in Q2 2026, an estimated $3.59M.
  • Fennec Pharmaceuticals made up 1.08% of AWM Investment Company's portfolio in Q2 2026, its #28 holding.
  • AWM Investment Company first reported a position in Fennec Pharmaceuticals in Q1 2023 and has held it in 4 quarters since.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on AWM Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.